+
 
For the best experience, open
m.thewire.in
on your mobile browser or Download our App.
You are reading an older article which was published on
Sep 20, 2021

India to Resume Export of Surplus COVID-19 Vaccines from October

Union health minister Mansukh Mandaviya said exports will resume under the Vaccine Maitri programme, in order to fulfil India's commitment towards COVAX.
Used syringes lie discarded in a bin after they were used to administer the coronavirus disease (COVID-19) vaccine in Mumbai, India, August 11, 2021. Photo: Reuters/Francis Mascarenhas

New Delhi: India will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the ‘Vaccine Maitri’ programme and to meet its commitment to the COVAX global pool, but vaccinating its own citizens remains the topmost priority of the government, Union health minister Mansukh Mandaviya said on Monday, September 20.

Addressing the media, the minister said the government will receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the next three months.

He also said that cumulative doses administered so far across the country have crossed 81 crore and the last 10 crore doses were administered in only 11 days.

Asserting that vaccination of our own citizens remains the government’s topmost priority, Mandaviya said the export of surplus vaccines would begin in the next quarter (October-December) under the Vaccine Maitri programme and in order to fulfil the commitment of India towards COVAX.

This is in line with our motto of ‘Vasudhaiva Kutumbakam’, he said.

He said that the surplus supply of vaccines will be used to fulfil India’s commitment towards the world for the collective fight against COVID-19.

Also read: India Considering Resuming Exports of COVID-19 Vaccines Soon: Report

COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO.

Highlighting the importance of indigenous research and production of COVID-19 vaccines in India, he said that it is due to the relentless efforts and guidance of Prime Minister Narendra Modi that India was simultaneously undertaking research and production of COVID-19 vaccines in such a big way.

India’s vaccination drive has been a role model for the world and it is marching ahead with great speed, he said.

Talking about the expected production and supply trends in the coming months, he said that more than 30 crore doses will be produced in October and more than 100 crores in the coming quarter.

India on Friday administered a record number of over 2.50 crore COVID-19 vaccine doses on the occasion of Prime Minister Narendra Modi’s 71st birthday.

The daily COVID-19 vaccination in the country was over 1 crore on September 6, August 31 and August 27.

India took 85 days to touch the 10-crore vaccination mark, 45 more days to cross the 20-crore mark and 29 more days to reach the 30-crore mark, according to the ministry.

The country took 24 days to reach 40 crore from 30 crore doses and then 20 more days to cross the 50-crore vaccination mark on August 6, it said.

It took 19 more days to go past the 60-crore mark and took only 13 days to reach 70 crore from 60 crore on September 7, the ministry said.

India, the ministry said, took just 11 more days to reach 80 crore from 70 crore.

Make a contribution to Independent Journalism
facebook twitter